Home  |   About us
ITEM PROTEIN ANTIBODY ASSAY KIT CELL
ELISA Kit for Bone Morphogenetic Protein 2 (BMP2)
BMP2A; BMP-2A; Hemochromatosis Modifier
Organism species Homo sapiens (Human)
Product No.SEA013Hu
Sample typeSerum, plasma, tissue homogenates and other biological fluids.
Format96-well strip plate
Assay length4.5 hours
Detection range15.625-1000pg/mL The standard curve concentrations used for the ELISA’s were 1000pg/mL, 500pg/mL, 250pg/mL, 125pg/mL, 62.5pg/mL, 31.25pg/mL, 15.625pg/mL
SensitivityThe minimum detectable dose of this kit is typically less than 5.5pg/mL.
Specificity
This assay has high sensitivity and excellent specificity for detection of Bone Morphogenetic Protein 2 (BMP2).
No significant cross-reactivity or interference between Bone Morphogenetic Protein 2 (BMP2) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Bone Morphogenetic Protein 2 (BMP2) and the recovery rates were calculated by comparing the measured value to the expected amount of Bone Morphogenetic Protein 2 (BMP2) in samples.
Matrix Recovery range (%) Average(%)
serum(n=5)88-10299
EDTA plasma(n=5)87-105101
heparin plasma(n=5)83-9186
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Bone Morphogenetic Protein 2 (BMP2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Bone Morphogenetic Protein 2 (BMP2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Bone Morphogenetic Protein 2 (BMP2) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample 1:2 1:4 1:8 1:16
serum(n=5)97-105%82-92%89-97%79-97%
EDTA plasma(n=5)80-95%94-101%91-105%82-104%
heparin plasma(n=5)81-101%82-90%87-95%94-102%
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1
Test principle
The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Bone Morphogenetic Protein 2 (BMP2). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Bone Morphogenetic Protein 2 (BMP2). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Bone Morphogenetic Protein 2 (BMP2), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Bone Morphogenetic Protein 2 (BMP2) in the samples is then determined by comparing the O.D. of the samples to the standard curve.
Package and Components
Assay procedure summary
1. Prepare all reagents, samples and
    standards;
2. Add 100µL standard or sample to each
    well. Incubate 2 hours at 37oC;
3. Aspirate and add 100µL prepared
    Detection Reagent A. Incubate 1 hour at
    37oC;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent
    B. Incubate 30 minutes at 37oC;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 15
    -25 minutes at 37oC;
8. Add 50µL Stop Solution. Read at 450nm
    immediately.
Reagent Preparation
Results demonstration
Typical Standard Curve
Download
Benchmark price
MagazineReference
PLoS ONE A Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic Approaches    Read more(Plosone: Source)
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications
MAA013Hu22Monoclonal Antibody to Bone Morphogenetic Protein 2 (BMP2)WB, ICC, IHC-P, IHC-F, ELISA
PAA013Hu01Polyclonal Antibody to Bone Morphogenetic Protein 2 (BMP2)WB, ICC, IHC-P, IHC-F, ELISA
PAA013Hu02Polyclonal Antibody to Bone Morphogenetic Protein 2 (BMP2)WB, ICC, IHC-P, IHC-F, ELISA
RPA013Hu01Recombinant Bone Morphogenetic Protein 2 (BMP2)SDS-PAGE; WB; ELISA; IP.
RPA013Hu02Recombinant Bone Morphogenetic Protein 2 (BMP2)SDS-PAGE; WB; ELISA; IP.
SCA013HuCLIA Kit for Bone Morphogenetic Protein 2 (BMP2)Chemiluminescent immunoassay
SEA013HuELISA Kit for Bone Morphogenetic Protein 2 (BMP2)Enzyme-linked immunosorbent assay